Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iva Brito

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Acta Reumatologica Portuguesa|January 20, 2011
Amyloidosis secondary to rheumatic diseases - 16 casesL Silva, Luzia Sampaio, Georgina Terroso, et al.
RMD Open|October 19, 2016
Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damageFilipa Oliveira-Ramos, Mónica Eusébio, Fernando M Martins, et al.
Journal of Immunology Research|October 28, 2015
Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.ptAna Filipa Mourão, Maria José Santos, Sílvia Mendonça, et al.
The Journal of Rheumatology|February 12, 2009
Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritisAna Filipa Mourão, Joana Caetano-Lopes, Paula Costa, et al.
Arthritis Care & Research|October 30, 2014
Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese registerAna F Mourão, Maria J Santos, José Melo-Gomes, et al.
Rheumatology (Oxford, England)|December 18, 2015
Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.ptAna F Mourão, Maria J Santos, José A Melo Gomes, et al.
ARP Rheumatology|May 28, 2022
The 2021 Portuguese Society of Ophthalmology joint guidelines with Paediatric Rheumatology on the screening, monitoring and medical treatment of juvenile idiopathic arthritis-associated uveitisInês Leal, Vasco Miranda, Cristina Fonseca, et al.
Journal of Autoimmunity|June 5, 2024
The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-CRoberta Caorsi, Alessandro Consolaro, Camilla Speziani, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Acta Reumatologica Portuguesa|January 20, 2011
Amyloidosis secondary to rheumatic diseases - 16 casesL Silva, Luzia Sampaio, Georgina Terroso, et al.
RMD Open|October 19, 2016
Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damageFilipa Oliveira-Ramos, Mónica Eusébio, Fernando M Martins, et al.
Journal of Immunology Research|October 28, 2015
Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.ptAna Filipa Mourão, Maria José Santos, Sílvia Mendonça, et al.
The Journal of Rheumatology|February 12, 2009
Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritisAna Filipa Mourão, Joana Caetano-Lopes, Paula Costa, et al.
Arthritis Care & Research|October 30, 2014
Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese registerAna F Mourão, Maria J Santos, José Melo-Gomes, et al.
Rheumatology (Oxford, England)|December 18, 2015
Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.ptAna F Mourão, Maria J Santos, José A Melo Gomes, et al.
ARP Rheumatology|May 28, 2022
The 2021 Portuguese Society of Ophthalmology joint guidelines with Paediatric Rheumatology on the screening, monitoring and medical treatment of juvenile idiopathic arthritis-associated uveitisInês Leal, Vasco Miranda, Cristina Fonseca, et al.
Journal of Autoimmunity|June 5, 2024
The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-CRoberta Caorsi, Alessandro Consolaro, Camilla Speziani, et al.
Pageof 5